English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Technology/Innovation

+ Technology/Innovation
Amanda Rupp | Mar 1, 2016

AstraZeneca releases results from tremelimumab monotherapy trial

+ Technology/Innovation
Kathy Adams | Mar 1, 2016

FDA approves XELJANZ XR as once-daily arthritis treatment

+ Technology/Innovation
Amanda Rupp | Mar 1, 2016

FDA approves drug for gastrointestinal, NET tumors

+ Regulatory
Whitney Wright | Mar 1, 2016

CMS updates questions concerning EHR incentive program

+ Community
Kerry Goff | Mar 1, 2016

UIC researcher believes new health care trends include high deductibles, 'value' ambiguity

+ Technology/Innovation
Kerry Goff | Mar 1, 2016

Rice University public policy director details effects of Obamacare

+ Regulatory
Kerry Goff | Feb 28, 2016

ER drug shortages getting worse with more FDA regulations

+ Community
Jamie Barrand | Feb 27, 2016

Educator pens book on how to help autistic children manage stress

Trending

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

  • « First
  • «
  • …
  • 470
  • 471
  • 472
  • 473
  • 474
  • 475
  • 476
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily